Abstract:: Alzheimer's disease (AD) is a degenerative disease of the nervous system. Mainly presenting with neuropsychiatric symptoms such as progressive memory impairment, cognitive dysfunction, personality changes, and language disorders [1] . Also known as senile dementia, it is the leading cause of dementia in the elderly [2] . Involved in 60-80% of all reports of dementia [3] . As the global population ages, AD prevalence and mortality rates increase. It seriously affects the quality of life of the elderly and brings a heavy economic burden and severe social problems. The tea polyphenol epigallocatechin gallate (EGCG) has preventive and therapeutic effects on Alzheimer's disease by inhibiting the amyloid formation and aggregation, antioxidant, anti-inflammatory, metal chelating, binding cholinesterase, thereby reducing the degradation of acetylcholine, and repairing mitochondrial dysfunction. This article reviews the research on the mechanism of EGCG action on Alzheimer's disease. necrosis and brain tissue damage have higher concentrations of Cu2 Zn2 +, and Fe3+ in the brain [50] , and EGCG has complexation for both Cu2 + and Fe3+ [51] The chelation of iron by EGCG interferes with iron-induced degradation and inactivation of iron regulatory protein (IRP1/2), leading to a decrease in amyloid precursor protein (APP) [52] It has been observed in electrochemistry and optics that EGCG inhibits the formation of Cu2+His complex by acting on Cu2+, thus reducing the formation of fiber [53] . EGCG also showed the ability to inhibit trivalent aluminum ion-induced Aβ42 fibrillation and significantly reduced Aβ42 toxicity by preventing further folding of Aβ42 monomers [54] . EGCG not only chelates free metal ions but also regulates the aggregation of Aβ after metal binding. In the effect of EGCG-bound metal ions on the structure of Aβ, it was found that the addition of EGCG to Cu 2+, Zn 2+ -bound Aβ generates free state Aβ aggregates, while structural Aβ aggregates are generated in metal-bound Aβ without the addition of EGCG [55] . These findings suggest that EGCG can compete with Aβ to bind metal ions, reduce APP production, prevent Aβ aggregation, and continue to inhibit Aβ aggregate binding after Aβ binding metal ions, thus preventing Aβ deposition and neurotoxicity.

Metal Chelator EGCG Attenuates Fe(III)‐induced Conformational Transition of Α‐synuclein and Protects AS‐PC12 Cells Against Fe(III)‐induced Death

(-)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of alpha-synuclein, and protects PC12 cells against alpha-synuclein-induced toxicity

Distinct Effects of Tea Catechins on 6-Hydroxydopamine-induced Apoptosis in PC12 Cells

Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of Α-Synuclein.

synuclein-induced toxicity

Effect of EGCG on Fe(III)‐induced Conformational Transition of Silk Fibroin, a Model of Protein Related to Neurodegenerative Diseases

EGCG Attenuates Α-Synuclein Protofibril-Membrane Interactions and Disrupts the Protofibril

Neuroprotective effect of green tea extract (-)-epigallocatechin-3-gallate in a preformed fibril-induced mouse model of Parkinson's disease

Epigallocatechin Gallate Destabilizes Α-Synuclein Fibril by Disrupting the E46-K80 Salt-Bridge and Inter-protofibril Interface.

Research progress of EGCG in the treatment of Alzheimer's disease

Ergothioneine rescues PC12 cells from β-amyloid-induced apoptotic death

Interference of EGCG on the Zn(ii)-induced Conformational Transition of Silk Fibroin As a Model Protein Related to Neurodegenerative Diseases

Protective effects of galantamine against Abeta-induced PC12 cell apoptosis by preventing mitochondrial dysfunction and endoplasmic reticulum stress.

EGCG Inhibited Lipofuscin Formation Based on Intercepting Amyloidogenic β-Sheet-Rich Structure Conversion

Inhibition of ferroptosis underlies EGCG mediated protection against Parkinson's disease in a Drosophila model

Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation

Egcg Inhibited Lipofuscin Formation Based On Intercepting Amyloidogenic Beta-Sheet-Rich Structure Conversion

Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats

Neurodegenerative diseases and catechins: (-)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress

Structural Insights of Fe 3+ Induced α-synuclein Fibrillation in Parkinson's Disease

Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide.